Gelteq (GELS) announced that in November, 400,000 units of its gel solution are entering into production. These units will fulfill orders made for clients in the U.S and Australia. Delivery is expected in January 2025 for sales across the two countries as well as in the UAE and in Asia. The production run includes Gelteq nutraceutical products in the areas of sports, anti-aging, and weight loss.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on GELS:
- Opening Day: Heritage Distilling, Dynamix open for trading
- Gelteq appoints Bendell as President of U.S. Operations
- Opening Day: Polyrizon, Gelteq debut in quiet IPO week
- Gelteq 1.3M share IPO priced at $4.00
- Gelteq opens at $4.00, IPO priced at $4.00
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
